Other clinicopathological variables, including age, smoking history, emphysema or tuberculosis, family history, distant metastasis, STAS, EGFR mutation, and ALK mutation, showed no correlation with SMARCA2 expression. Here, EGFR is linked to pulmonary emphysema.